These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 28720173)

  • 41. Ion-pair chromatography for simultaneous analysis of ethionamide and pyrazinamide from their porous microparticles.
    Bhanushali CJ; Zidan AS; Rahman Z; Habib MJ
    AAPS PharmSciTech; 2013 Dec; 14(4):1313-20. PubMed ID: 23990078
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HPLC determination of rifampicin and related compounds in pharmaceuticals using monolithic column.
    Liu J; Sun J; Zhang W; Gao K; He Z
    J Pharm Biomed Anal; 2008 Jan; 46(2):405-9. PubMed ID: 18055155
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potential of multisyringe chromatography for the on-line monitoring of the photocatalytic degradation of antituberculosis drugs in aqueous solution.
    Guevara-Almaraz E; Hinojosa-Reyes L; Caballero-Quintero A; Ruiz-Ruiz E; Hernández-Ramírez A; Guzmán-Mar JL
    Chemosphere; 2015 Feb; 121():68-75. PubMed ID: 25434276
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in HIV-infected Indian children.
    Mukherjee A; Velpandian T; Singla M; Kanhiya K; Kabra SK; Lodha R
    Int J Tuberc Lung Dis; 2016 May; 20(5):666-72. PubMed ID: 27084822
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics of Antituberculosis Drugs in HIV-Positive and HIV-Negative Adults in Malawi.
    van Oosterhout JJ; Dzinjalamala FK; Dimba A; Waterhouse D; Davies G; Zijlstra EE; Molyneux ME; Molyneux EM; Ward S
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6175-80. PubMed ID: 26248378
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Analytical determinations of antitubercular drugs and their possible associated interferences].
    Alberghina M
    Lotta Tuberc; 1971; 41(3):324-37. PubMed ID: 5291091
    [No Abstract]   [Full Text] [Related]  

  • 47. Determinants of rifampin, isoniazid, pyrazinamide, and ethambutol pharmacokinetics in a cohort of tuberculosis patients.
    McIlleron H; Wash P; Burger A; Norman J; Folb PI; Smith P
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1170-7. PubMed ID: 16569826
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The pharmacokinetics of a single oral or rectal dose of concurrently administered isoniazid, rifampin, pyrazinamide, and ethambutol in Asian elephants (Elephas maximus).
    P Brock A; Isaza R; Egelund EF; Hunter RP; Peloquin CA
    J Vet Pharmacol Ther; 2014 Oct; 37(5):472-9. PubMed ID: 24684601
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment outcomes of fixed-dose combination versus separate tablet regimens in pulmonary tuberculosis patients with or without diabetes in Qatar.
    Al-Shaer MH; Mansour H; Elewa H; Salameh P; Iqbal F
    BMC Infect Dis; 2017 Feb; 17(1):118. PubMed ID: 28152986
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effectiveness of RHZE-FDC (fixed-dose combination) compared to RH-FDC + Z for tuberculosis treatment in Brazil: a cohort study.
    Braga JU; Trajman A
    BMC Infect Dis; 2015 Feb; 15():81. PubMed ID: 25879615
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Comparative data regarding two HPLC methods for determination of isoniazid].
    Gârbuleţ D; Spac AF; Dorneanu V
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1285-8. PubMed ID: 20191915
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systemic exposure to rifampicin in patients with tuberculosis and advanced HIV disease during highly active antiretroviral therapy in Burkina Faso.
    Saleri N; Dembélé SM; Villani P; Carvalho AC; Cusato M; Bonkoungou V; Nacanabo R; Kouanda S; Comelli M; Regazzi M; Matteelli A
    J Antimicrob Chemother; 2012 Feb; 67(2):469-72. PubMed ID: 22028201
    [TBL] [Abstract][Full Text] [Related]  

  • 53. LC-MS/TOF and UHPLC-MS/MS study of in vivo fate of rifamycin isonicotinyl hydrazone formed on oral co-administration of rifampicin and isoniazid.
    Prasad B; Singh S
    J Pharm Biomed Anal; 2010 Jul; 52(3):377-83. PubMed ID: 19692195
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro analysis of rifampicin and its effect on quality control tests of rifampicin containing dosage forms.
    Agrawal S; Panchagnula R
    Pharmazie; 2004 Oct; 59(10):775-81. PubMed ID: 15544056
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Simultaneous HPLC assay for pretomanid (PA-824), moxifloxacin and pyrazinamide in an inhaler formulation for drug-resistant tuberculosis.
    Momin MAM; Thien SJ; Krittaphol W; Das SC
    J Pharm Biomed Anal; 2017 Feb; 135():133-139. PubMed ID: 28024261
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group.
    Gordin F; Chaisson RE; Matts JP; Miller C; de Lourdes Garcia M; Hafner R; Valdespino JL; Coberly J; Schechter M; Klukowicz AJ; Barry MA; O'Brien RJ
    JAMA; 2000 Mar; 283(11):1445-50. PubMed ID: 10732934
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Substandard tuberculosis drugs on the global market and their simple detection.
    Laserson KF; Kenyon AS; Kenyon TA; Layloff T; Binkin NJ
    Int J Tuberc Lung Dis; 2001 May; 5(5):448-54. PubMed ID: 11336276
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bioequivalence of isoniazid in a two drug fixed dose combination and in a single drug dosage form.
    Agrawal S; Kaul CL; Panchagnula R
    Pharmazie; 2001 Aug; 56(8):636-9. PubMed ID: 11534341
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bioequivalence of fixed-dose combination Myrin®-P Forte and reference drugs in loose combination.
    Wang HF; Wang R; O'Gorman M; Crownover P; Naqvi A; Jafri I
    Int J Tuberc Lung Dis; 2013 Dec; 17(12):1596-601. PubMed ID: 24200275
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis.
    Botha FJ; Sirgel FA; Parkin DP; van de Wal BW; Donald PR; Mitchison DA
    S Afr Med J; 1996 Feb; 86(2):155-8. PubMed ID: 8619142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.